| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | 10% Owner
2 companies
Finn Jonathan serves as a Director at ATOS and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $30K at current prices.
The biggest single holding is ATOS (~$28K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 25,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 10, 2024 | ATOS Atossa Therapeutics, Inc. | Director | Buy | 25,000 | $1.77 | $44,250.00 | New | -34.3% | -66.3% |